Halbert Hargrove Global Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Halbert Hargrove Global Advisors's JAZZ Position: Q3 2026 in Review
Halbert Hargrove Global Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2026, closing a stake of 1 share — an estimated $225 sold.
Halbert Hargrove Global Advisors first reported a position in JAZZ in Q3 2025 and held it in 2 quarters. The position peaked at $923 in Q3 2025. 668 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Halbert Hargrove Global Advisors reported no remaining Jazz Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Halbert Hargrove Global Advisors sold 1 Jazz Pharmaceuticals share in Q3 2026, an estimated $225.
- Halbert Hargrove Global Advisors first reported a position in Jazz Pharmaceuticals in Q3 2025 and held it in 2 quarters.
- Halbert Hargrove Global Advisors's Jazz Pharmaceuticals position peaked at $923 in Q3 2025.
- 668 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Halbert Hargrove Global Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.